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Abstract: 
Objective: The Joint Effort Initiative was endorsed by Osteoarthritis Research Society International 
(OARSI) in 2018 as a collaboration between international researchers and clinicians with an interest in 
the implementation of osteoarthritis management programs (OAMPs). This study aimed to identify and 
prioritise activities for future work of the Joint Effort Initiative.  
Design: A survey was emailed to delegates of the 2018 OARSI World Congress attending a pre-
conference workshop or with a known interest in OAMPs (n=115). Delegates were asked about the most 
important issues regarding OAMP implementation. The top 20 issues were synthesised into 17 action 
statements, and respondents were invited to participate in a priority ranking exercise to determine the 
order of importance of the statements.  
Results: Survey respondents (n=51, 44%) were most commonly female (71%), with an allied health 
background (57%), affiliated with universities (73%) from Oceania (37%), and Europe/UK (45%). The five 
highest ranked action statements were:  
i) Establish guidelines for the implementation of different OAMP models to ensure 
consistency of delivery and adherence to international best practice.  
ii) Develop and assess training and education programs for health care professionals 
(HCPs) delivering OAMPs. 
iii) Develop and evaluate the implementation and outcomes of novel models of OAMPs. 
iv) Develop and assess core skill sets and resources for HCPs delivering OA care.  
v) Develop a framework for enhancing the quality of care provided by OAMPs.  
Conclusion: Prioritising statements will bring focus to the future work of the Joint Effort Initiative in the 
future and provide a basis for longer-term actions. 
Key words:  Consensus, osteoarthritis, chronic care, management programs, priority setting  
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Priorities for the effective implementation of osteoarthritis management programs: an OARSI 1 
international consensus exercise.  2 
 3 
Introduction  4 
Osteoarthritis (OA) is a leading cause of global disability (1, 2). The prevalence of this disabling condition 5 
is projected to rise rapidly in the presence of an aging population and increasing rates of obesity (3). 6 
International guidelines make clear, consistent recommendations for evidence-based management of 7 
OA (4). There is relative consensus amongst these guidelines that hip and knee OA management should 8 
be tailored to the individual and include the following three core effective, non-surgical, non-9 
pharmacological interventions: i) self-management and OA education; ii) exercise; and iii) weight loss for 10 
people with hip or knee OA who are overweight or obese (5). Serious discrepancy remains between 11 
these recommendations and the actual care received by patients, particularly underutilisation of the 12 
three core treatments (6) and over-reliance on pharmacological agents and surgery (7). This discrepancy 13 
may be attributed to the following factors: inadequate time available to deliver complex interventions, 14 
lack of support for  behaviour change, exercise interventions are undervalued, clinicians believe they are 15 
under-prepared, and dissonant patient expectations (8, 9).  16 
 17 
In order to address evidence-practice gaps, several specialist osteoarthritis management programs 18 
(OAMPs) have been developed and implemented internationally (10). These OAMPs aim to deliver 19 
coordinated, evidence-based care for people with OA. We have operationally defined an OAMP as a 20 
model of evidence-based, non-surgical OA care that has been implemented in a real-world setting, and 21 
comprises the following four components:  22 
i) personalised OA care - (tailored to the individual needs of the patient);  23 
ii) provided as a package of care with longitudinal reassessment and progression; 24 
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iii) comprising two or more components of the core, non-surgical, non-pharmacological interventions 25 
(education, exercise, and weight-loss) and;  26 
iv) optional evidence-based adjunctive treatments as required (e.g. assistive devices, psychosocial 27 
support).  28 
The objectives of these programs are to help individuals address their pain, stiffness and loss of function, 29 
while improving their quality of life and maintaining independence. Existing OAMP service delivery 30 
models have been tailored to local contextual features and hence are all very different (10). However, 31 
the core components of OAMPs consistently include education around OA, support for self-32 
management, exercise programs and promotion of increased physical activity. These are often 33 
combined with other evidence-based therapies when indicated such as: weight loss interventions; 34 
psychological support; review of analgesics and prescription of assistive devices (10). The international 35 
development of OAMPs is still in its infancy, and there is a pressing need for coordinated, broad-scale 36 
strategies to ensure the implementation of high quality, evidence-based programs as these are adapted 37 
to meet local needs. 38 
 39 
The majority of OAMPs are available at a relatively small-scale, in high-income countries with stable 40 
healthcare systems within Europe, North America and Australasia (11-16). A recent review has 41 
highlighted the need to develop, implement and evaluate models of service delivery across the 42 
spectrum of OA disease and pointed to the dearth of OAMPs in low- and middle-income countries (10). 43 
In response to growing international interest in OAMPs, a group comprised mainly of researchers and 44 
clinicians have established the ‘Joint Effort’ Initiative which was endorsed by the Osteoarthritis Research 45 
Society International (OARSI) in 2018. The Initiative seeks to provide a structure whereby activity related 46 
to implementation of OAMPs may be harmonised and standardised, particularly around optimising the 47 
quality and delivery of care, health professional training, fostering international research collaborations, 48 
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while minimising duplication of effort and resources. The Initiative’s mission is to investigate the most 49 
effective OAMP models to use, develop long-term strategies for effective implementation in different 50 
socioeconomic and cultural environments while ensuring the health professional workforce is 51 
appropriately skilled to deliver high-quality care and to help identify research priorities to facilitate best-52 
practice care.  53 
 54 
The first action of the Initiative was to identify and prioritise activities for future work. The prioritisation 55 
exercise was undertaken in two parts. Firstly, we invited delegates at the 2018 OARSI World Congress in 56 
Liverpool UK who were interested in OAMPs to participate in a survey. We sought their views on the 57 
most important issues surrounding the international implementation of OAMPs, and to identify 58 
potential gaps for further research. Following this broad survey, interested respondents were invited to 59 
participate in a prioritisation exercise to rank the top priorities for future action. This paper presents the 60 
findings and priorities identified by the survey and outlines the future actions of the Initiative.  61 
 62 
Method 63 
An overview of the process is outlined in Figure 1.  64 
 65 
Participants 66 
We sent an email invitation to all delegates of the 2018 OARSI World Congress who were attending a 67 
pre-conference workshop or had a known interest in OAMPs (n=115) to complete a survey (Survey 1).  68 
We then invited all consenting respondents to participate in a prioritisation exercise to rank the top 69 
priorities (Survey 2). Ethical approval was granted by the Human Research Ethics Committee of the 70 
University of Sydney (2018/262), and the survey was endorsed by the 2018 OARSI Conference 71 
Organisers. A study information sheet was provided to potential participants, and completion of the 72 
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survey was considered indicative of informed consent to participate. Participation was voluntary, and 73 
only completed surveys were included in the analyses. 74 
 75 
The surveys 76 
Two custom-designed surveys were developed for this study.  77 
Survey 1 78 
The first survey was designed to seek participants’ views on the most important issues that need to be 79 
addressed concerning the international implementation of OAMPs. A link to the survey was emailed to 80 
participants attending the OARSI pre-congress meeting two days before the event (24th April, 2018) via 81 
REDCap, a secure web-based application (17). Following requests from the delegates, the survey 82 
remained open for 17 days until the 10th May, 2018 to allow participants to complete the survey once 83 
they returned home from the congress.  84 
 85 
The survey took 10-15 minutes to complete. The first section asked questions about the respondent’s 86 
demographics and their prior experience with OAMPs (see Appendix 1). In the second section, 87 
participants were asked to identify three issues they considered important for implementation of 88 
OAMPs that should be addressed. This free-text section was presented first so participant answers were 89 
not influenced by the multiple-choice options. The remainder of the survey presented multiple-choice 90 
questions spanning the three domains drawn from the Donabedian framework for quality assessment in 91 
healthcare (18) and a fourth domain focussed on research priorities. The domains were defined as: 92 
i) Structural and environmental considerations: attributes of the setting or environment in 93 
which healthcare occurs, including material resources, human resources and organisational 94 
structure.  95 
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ii) Process and implementation considerations: how the person seeks care and the healthcare 96 
professional provides care.    97 
iii) Outcome considerations: the effects of care on the health of the person including changes in 98 
knowledge and behaviour. 99 
iv) Areas for OA management program implementation research: potential research questions 100 
raised at previous OARSI meetings by delegates with an interest in OAMPs. 101 
Finally, an open-ended question asked respondents to identify any considerations or research questions 102 
that had not been previously identified. Between seven and 13 multiple-choice options were provided 103 
for the four domains above. The options for each domain were developed following discussions 104 
amongst participants at previous OARSI OAMP workshops (Amsterdam, 2016 and Las Vegas, 2017), 105 
through literature review and consensus from the authors of this paper. The survey participants were 106 
asked to select the three options within each domain that they considered to be the most important 107 
issues for implementation of OAMPs. A full list of the survey questions is provided in the supplementary 108 
materials. 109 
 110 
Survey 2 111 
Using data from survey 1, action statements were developed for the prioritisation exercise conducted in 112 
survey 2. We compiled a list of the top 20 options chosen by participants in survey 1 derived from the 113 
top three rated options to each of the four domains (12 topics), then the next eight highest ranked 114 
options irrespective of the domain. The free-text responses were extracted from the database, and 115 
coded thematically (JB and JE), with reference to the multiple-choice topics. Three additional topics 116 
were identified (see Results), however these weren’t identified with adequate consistency to justify 117 
inclusion as separate action statements. Specific action statements were then developed for each 118 
general topic aligned to the terms of reference of the Initiative and were deliberately broad in scope. 119 
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They were checked for overlap by the authors, and 17 action statements were ultimately circulated for 120 
final prioritisation. Three of the original 20 topics were merged with others as they could be covered by 121 
one action statement (see Table 2).  122 
 123 
Participants of the prioritisation exercise were sent a link via the 1000minds software 124 
(www.1000minds.com) June 2018 and were given two weeks for completion. 1000minds is a decision-125 
analysis research tool that prioritises statements according to their relative importance to the 126 
participant. Pairwise-ranking presented the participants with two action statements and asked, “Which 127 
of the following two options do you think is the higher priority to address?”. This process was repeated 128 
until all 17 action statements were ranked using the minimum number of presentations. 129 
 130 
Data analysis 131 
De-identified individual data were downloaded from REDCap and 1000minds and exported to an Excel 132 
file. Descriptive statistics summarised demographic and survey data. Data are presented as frequency 133 
data for options of the four domains in survey 1 and ranked according to frequency. The data outputted 134 
from survey 2 using 1000minds included mean and median rankings for each action statement. 135 
Interquartile ranges were calculated in Excel for each action statement.  136 
  137 
Results 138 
Participant Demographics 139 
Of the 115 people invited to participate in survey 1, 51 (44%) of invitees completed responses (Table 1). 140 
Of the 40 participants who consented to be contacted further for Survey 2, 26 (65%) participants 141 
provided complete responses. There were no major differences observed in the characteristics of 142 
respondents between the surveys because the second survey comprised a subset of the respondents 143 
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from survey 1. Most respondents were female for surveys 1 and 2 (71% and 65% respectively) and 144 
approximately 50% had an allied health background. More than half of respondents in both surveys 145 
were affiliated with a university. There were representatives from 12 countries in survey 1 and nine 146 
countries in survey 2.  Most respondents were from Europe/UK and Oceania. There were no 147 
representatives from the African region, and only one from Asia and South America.  While a third of 148 
respondents were practising clinicians, all reported involvement in research, most held a PhD 149 
qualification. The mean years of experience was 13.6 (SD 8.00) years in survey 1 and 12.5 (SD 8.83) years 150 
in survey 2. 151 
  152 
Results of Survey 1 153 
Current management programs  154 
Seventy-three percent of participants (n=37) reported working with OAMPs, most frequently in a 155 
research capacity. The settings for these programs were primary care (n=17), embedded within clinical 156 
trials (n=15), community-based settings (n=15), public hospitals (n=9), private hospitals (n=8), private 157 
clinics or university clinics (both n=7) or commercial programs (n=3). Four respondents reported working 158 
outside traditional models of healthcare delivery, including via online platforms, patient advocate 159 
organisations, and private health insurance programs. All stages of program implementation were 160 
represented (planning stage 17%, piloting program 36%, established and growing 36%, and established 161 
and stable 31%).     162 
 163 
Results of multiple-choice questions  164 
Results from survey 1 are presented in Figure 2. The top 3 considerations selected for each domain 165 
were:  166 
i) Structural / environmental considerations:  167 
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1) operational funding for OAMPs,  168 
2) incorporation of OAMPs into different healthcare systems, and  169 
3) stakeholder engagement.  170 
Reimbursement for participants to undertake OAMPs and increased engagement with healthcare 171 
policy were also important. 172 
ii) Process and implementation considerations: 173 
1) the mode of delivery of the programs, 174 
2) development of specialised clinical skill sets for HCPs working with OAMPs, and 175 
3) provision of accurate, up-to-date information for OAMP consumers.  176 
The next most frequently occurring topics were training for HCPs working in OAMPs, staying up-to-177 
date with current evidence (e.g. knowledge translation) and developing an overarching framework 178 
for implementing OAMPs.   179 
iii) Outcome considerations: 180 
1) managing therapeutic effects and ensuring behaviour change, 181 
2) ensuring both HCPs and consumers engaged with the program, and 182 
3) development of self-management capabilities. 183 
The next most important outcome consideration was ensuring OAMPs were cost-effective.   184 
iv) Research priorities:  185 
1) comparing clinical outcomes and cost-effectiveness of the programs, 186 
2) training for HCPs delivering OAMPs, and 187 
3) developing and testing novel models for OAMPs. 188 
The next most frequent option chosen for research priorities was improving adherence to 189 
international guidelines.    190 
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Other considerations raised  191 
Free text fields allowed respondents to identify additional issues considered important for 192 
implementation of OAMPs. Additional topics raised in this section, that were not included in the final 193 
action statements, were: 194 
• ensure care delivered is personalised, 195 
• address prevention and monitor disease progression in the programs, and 196 
• marketing and promotion of the programs. 197 
 198 
Results of Survey 2 199 
The final ranked list of priority action statements from survey 2 are presented in Table 2. The top five 200 
ranked statements were:  201 
i. Establish guidelines for the implementation of different OAMP models to ensure consistency of 202 
delivery and adherence to international best practice.  203 
ii. Develop and assess training and education programs for HCPs delivering OAMPs. 204 
iii. Develop and evaluate the implementation and outcomes of novel and innovative models or 205 
pathways of OAMPs. 206 
iv. Develop and assess core skill sets and resources for HCPs delivering specialised OA care 207 
including those who operate with an extended scope of practice.  208 
v. Develop a framework for enhancing the quality of care provided to people living with OA who 209 
engage with OAMPs including measurement of care quality and strategies for improvement. 210 
The next highest-ranked priorities covered the themes of encouraging engagement of both consumers 211 
and HCP with the programs, evaluation of the cost of running OAMPs, and how they operate within local 212 
policy and healthcare environments. Securing operational funding for programs did not feature in the 213 
final top 10 priorities, even though it received a lot of support in the initial survey.   214 
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Discussion  215 
As part of a coordinated response to the global rise in the burden of chronic disease, the World Health 216 
Organization (WHO) has released a global strategy to promote the implementation of integrated, 217 
people-centred health services. This strategy requires a fundamental paradigm shift in the funding, 218 
management and delivery of healthcare services (19) and requires the establishment of guidelines as to 219 
how these new, complex models of care may be implemented. Models of care for musculoskeletal 220 
health take the recommendations for evidence-based care (the ‘what’) and provide the ‘how’ regarding 221 
implementation of these recommendations. The model of care has been described as providing the right 222 
care, at the right time, in the right place, with the right team, using the right resources (20). The highest 223 
ranked action statement identified in this study was to ‘establish guidelines for the implementation of 224 
different OAMP models to ensure consistency of delivery and adherence to international best practice 225 
models of care’. The participants also felt that further work is required to assist international groups to 226 
achieve the changes to health service delivery necessary to establish OAMPs by providing guidance 227 
regarding not only the content, but also the processes that support the implementation of these 228 
programs. 229 
 230 
An essential attribute of these major changes to health service delivery is the need to reorient and 231 
educate the health workforce (21). This, coupled with the knowledge that health outcomes are largely 232 
dependent on the quality of training and capabilities of health care professionals (HCPs) are important 233 
drivers for the need to build workforce capacity to support models of care such as OAMPs (22). 234 
Deficiencies have been identified in the current and emerging global healthcare workforces regarding 235 
the capacity and capability to manage coordinated/integrated services such as OAMPs. There are 236 
chronic shortages of HCPs responsible for managing musculoskeletal disorders across all professions, 237 
particularly across low- and middle-income countries and in regional/rural areas (23). 238 
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 239 
There is growing evidence of a clear deficit in professional capabilities that limits the implementation of 240 
optimal evidence-based OA care in healthcare (24). Several major barriers to the implementation of 241 
evidence-based OA care have been identified (24, 25). Important common themes include that clinicians 242 
feel under-prepared in terms of knowledge and skills to deliver treatments recommended by OA 243 
management guidelines, and clinicians report doubts about the effectiveness of treatments for OA. 244 
Given this evidence, it is unsurprising that the second most highly ranked action identified was the 245 
development of training and education programs for HCPs delivering care in OAMPs. The fourth highest 246 
ranked priority was closely related, and concerned the skills, confidence and training (including core 247 
competencies) of health professionals delivering OAMPs. 248 
 249 
Some work has been done to address the perceived lack of training, knowledge and skills for health 250 
practitioners in general. A systematic review in 2010 identified that there was sparse literature available 251 
at the time regarding the effectiveness of educational strategies used to improve professional 252 
behaviours in the implementation of guidelines for OA management (26). Since this review there have 253 
been several studies that have tested different strategies to improve the expertise of HCPs to deliver 254 
recommended OA care. A Canadian observational study of the Getting a Grip on Arthritis© program 255 
followed 553 HCPs in primary care for six months following inter-professional education workshops and 256 
found significant improvements in best practice scores for knee OA cases (27). Two Dutch randomised 257 
controlled trials tested the effectiveness of an interactive workshop approach to educating HPCs about 258 
implementation of the Dutch physiotherapy guideline for hip and knee OA. The interactive workshop 259 
was found to improve HCP guideline knowledge and adherence (28, 29).  260 
 261 
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The Management of OsteoArthritis In Consultations (MOSAICS) study in the United Kingdom tested the  262 
clinical and cost-effectiveness of a model OA consultation (MOAC) that implemented the National 263 
Institute for Health and Care Excellence (NICE) guidelines for OA management in primary care (30). A 264 
key component of this trial was to develop and evaluate a training package for management of OA by 265 
GPs and practice nurses. The MOAC was developed in consultation with GPs and patients using a Delphi 266 
consensus exercise (31, 32) following which the practice nurse training program to support the MOAC 267 
was developed and tested (32). The MOAC was tested in a cluster randomised controlled trial in 10 268 
general practices and demonstrated improvement in the implementation of the core NICE guidelines for 269 
OA care in the intervention group compared with controls (13). Given the accumulated evidence 270 
regarding the use of educational interventions to improve the implementation of OA management 271 
guidelines, it is logical to consider the combined findings of this body of evidence and focus future 272 
efforts on harmonising rather than replicating the development of training and education programs for 273 
HCPs delivering care in OAMPs. Identifying the core capabilities required of HCPs to deliver high-quality 274 
OA care is the necessary first step and is work currently underway through the Initiative. 275 
 276 
OAMPs have been implemented internationally and tested across a variety of settings including teaching 277 
hospitals (e.g. Osteoarthritis Chronic Care Program) (14), university clinics (e.g. Amsterdam 278 
Osteoarthritis Cohort) (33) physiotherapy clinics (e.g. ActiveA, Good Living with OA Denmark and Better 279 
Living with OA) (12, 15), community care (e.g. ESCAPE-PAIN) (11) and general practice (e.g. PARTNER 280 
model, MOSAICS and the SAMBA model) (13, 34, 35). Yet, there are many parts of the world that have 281 
not yet implemented OAMPs within their health systems. There is a raft of reasons why OAMPs have not 282 
become established uniformly across the world, and many of the perceived barriers and enablers to the 283 
management of OA have been synthesised in a recent systematic review (24). There were no enablers 284 
reported, but several barriers were identified including the perception that OA as a condition is not that 285 
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serious and is seen as a comorbidity in the context of other conditions (e.g. cardiovascular disease, 286 
diabetes)(2). This perception has further compounded system-related barriers to the implementation of 287 
evidence-based OA care (36). Where the health policy and infrastructure required to support 288 
differentiated OAMPs is lacking, new, innovative models of care might prove to provide at least part of 289 
the solution. New models of OA care service delivery utilising technology such as telehealth, online 290 
consultations and online platforms have been designed and are being tested in current research (37-40). 291 
The third highest ranked activity statement of the Initiative was to ‘develop and evaluate the 292 
implementation and outcomes of novel and innovative models or pathways of OAMPs’.  293 
 294 
As these new models of service delivery for OAMPs are developed, tested and implemented, it is very 295 
important to consider the quality of OA care delivered across these programs. This was ranked the fifth 296 
most important consideration for future action in the Initiative consensus exercise. Quality care 297 
indicators were used to measure uptake of core non-surgical OA management in the MOSAICS study 298 
(13). These quality indicators and other metrics that reflect whether the core components of OA 299 
management are met (i.e. education around OA, support for self-management, exercise programs and 300 
promotion of increased physical activity (10)) would go a long way to ensure the provision of consistent, 301 
quality care across all international programs.  302 
 303 
There are several limitations to note with this study. First, the survey was limited to people attending 304 
the OARSI meeting, or who were existing members of the Initiative. Second, the participants of the 305 
survey, and the Initiative generally hail from high-income nations, have pre-existing involvement with 306 
OAMPs, and a strong research focus. Consequently, we received minimal input from lower- or middle-307 
income countries, countries outside Western Europe and Australia. The disproportionate representation 308 
of our respondents may be due in part to the 2018 OARSI meeting being hosted in the UK, but is 309 
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probably more related to the lack of OAMPs internationally (10) and the ad-hoc approach to their 310 
development. This important limitation is being addressed as an immediate priority by the Initiative. The 311 
Initiative Steering Committee now includes representatives from North America and Asia. We are 312 
currently inviting researchers and HCPs particularly from Africa, Asia, Central and South America to 313 
engage with the Initiative.  Finally, the participants of this study were mostly academics, a smaller 314 
proportion were clinicians, while patients and the public were not consulted. It is crucial that all end-315 
users including clinicians, patients and the public are engaged in this work. A North American consumer 316 
advocacy organisation now has representation on our steering committee, and we are currently 317 
developing strategies to involve HCPs, people with OA and the general public in our work.  318 
 319 
The findings from this study are generic and should cross international borders. However, further 320 
discussions around implementation in different health systems and settings are critical as an ongoing 321 
focus of the Initiative. We have recently had a “Discussion Group” endorsed by OARSI and will use this 322 
forum to encourage greater participation in the Initiative’s broader activities. .      323 
 324 
Future actions  325 
In addition to expanding our engagement and collaboration activities, the Initiative has proposed four 326 
working groups to address the areas prioritised. They will be: 327 
• Core Capabilities: This group is currently working to identify the core capabilities required of 328 
HCPs to deliver high-quality OA care. These core capabilities will provide a framework for the 329 
future development of strategies for training and educational activities. The working group is 330 
presently undertaking an international scoping exercise and is actively seeking input from 331 
consumers and clinicians.    332 
 333 
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• Training and Educational Resources: This group will develop and evaluate a professional 334 
training and education program for HCPs delivering OAMPs. 335 
 336 
• OA management program implementation: This group will seek to develop guidelines for the 337 
broad scale implementation of OAMPs. This may involve developing a compendium of 338 
information for HCPs, policy makers and consumers from different existing resources. New 339 
resources may also be developed as required. These resources will focus on ensuring that 340 
OAMPs meet the core recommendations for OA care and provide support for developing 341 
OAMPs. 342 
 343 
• Outcomes of OAMPs: A working group will be assembled to work on developing a core set of 344 
outcome measures for OAMPs. This will enable the testing and comparison of existing and novel 345 
models of OA care service delivery particularly the comparison of clinical versus cost-346 
effectiveness. Systems that include the ability to share data will also enable comparative 347 
effectiveness studies. A long-term goal may be to establish and maintain a data repository to 348 
facilitate future research of OAMPs. 349 
 350 
Conclusion 351 
 Prioritizing statements will bring focus to the future work of the Joint Effort Initiative in the immediate 352 
future and provide a basis for longer-term actions.  353 
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 495 
Figure Legends 496 
 497 
Figure 1: Overview of the prioritisation process.  498 
 499 
Figure 2: Total number of responses received to multiple-choice options in each domain. A maximum 500 
of 3 responses were allowed for each domain. 501 
  502 
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Table 1: Participant demographics for survey 1 and survey 2. (*) designates multiple answers were 503 
allowed for that question.  504 
 Survey 1 
n (%) unless otherwise 
stated 
Survey 2 
n (%) unless otherwise 
stated 
Total completed responses 51 (44) 26 (65) 
Sex  
Female 
 
36 (71) 
 
17 (65) 
Region  
Asia 
Europe/UK 
Oceania 
North America 
South America 
 
1 (2) 
23 (45) 
19 (37) 
7 (14) 
1 (2) 
 
1 (4) 
10 (38) 
12 (46) 
3 (12) 
0 
Primary affiliation 
University 
Hospital / other medical  
Other research 
 
37 (73) 
12 (23) 
2 (4) 
 
19 (73) 
6 (23) 
1 (4) 
Profession 
Medical 
Allied Health 
Scientist 
Other 
 
14 (27) 
29 (57) 
5 (10) 
3 (6) 
 
10 (38) 
12 (46) 
3 (12) 
1 (4) 
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Current role  
Allied Health  
Medical 
Researcher 
Educator/lecturer 
Public health/policy 
Other 
n=67* 
3 
7 
47 
7 
2 
1 
n=35* 
1 
6 
24 
2 
2 
- 
Practicing clinician 
yes 
 
16 (31) 
 
10 (38) 
Years of experience mean years 
(SD) 
13.6 (8.00)  12.5 (8.83) 
Involved in research  
yes 
 
50 (100) 
 
26 (100) 
Highest degree 
PhD 
MD 
Masters by Research 
Completing PhD 
 
36 (70) 
2 (4) 
4 (8) 
9 (18) 
 
17 (65) 
1 (4) 
2 (8) 
6 (23) 
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Table 2: Top 20 topics identified from Survey 1 and the respective action statements developed for each. Results are ranked in order by the 
highest priority topics identified by survey 2. A lower median value means participants rated this action as a higher priority for OAMP 
implementation.  
Rank 
survey 1 
Topic presented 
in Survey 1 
Action statement presented 
in Survey 2 
Median 
Rank 
(IQR) 
Action  
statement 
ranking 
8 
Mode of delivery of the OA 
Management Program 
Establish guidelines for the implementation of different OA 
Management Program models to ensure consistency of delivery 
and adherence to international best practice (see 7) 
6.25 8.88 1 
7 
Implementation and adherence 
to international OA guidelines 
Incorporated into statement 8 above - - 1 
18 
Training for OA management 
program personnel 
Develop and assess training and education programs for HCPs 
delivering OA Management Programs 
7.00 8.38 2 
6 
Novel models or pathways of 
OAMP 
Develop and evaluate the implementation and outcomes of novel 
and innovative models or pathways of OA Management Programs 
7.50 8.38 3 
9 
Skills, confidence and training 
(including core competencies) 
of health professionals 
Develop and assess core skill sets and resources for HCPs 
delivering specialised OA care including those who operate with an 
extended scope of practice.  
7.50 8.38 3 
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delivering the OAMP 
1 
Managing therapeutic effects / 
behaviour change 
Incorporated into statement 9 above - - 3 
11 
Quality of the OA care provided 
for consumers 
Develop a framework for enhancing the quality of care provided to 
people living with OA who engage with OAMPs including 
measurement of care quality and strategies for improvement. 
7.75 6.37 4 
19 
Developing consumer self-
management  
Develop, assess and compare programs in community settings (e.g. 
care managers/ coordinators/teams) that aim to support self-
management for people living with OA 
8.50 6.87 5 
16 
Consumer engagement with the 
OAMP 
Develop and assess strategies to enhance the engagement of 
people living with OA with OA Management Programs including 
uptake and adherence.  
8.50 7.25 5 
15 
Health-care provider 
engagement with the program 
Evaluate and develop strategies to enhance the engagement of all 
relevant health providers with OA Management Program models 
of care 
8.75 5.25 6 
2 
Comparison of clinical outcomes 
and cost 
Develop, evaluate and compare clinical outcomes vs cost-
effectiveness for the delivery of different models of OA 
Management Programs 
8.75 7.0 6 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
28 
 
20 Cost-effectiveness of OAMPs Incorporated into statement 2 above - - 6 
4 Health care system 
Evaluate the implementation of OA Management Programs, and 
how they operate within different healthcare systems (e.g. 
government supported vs user-pays) 
8.75 8.63 6 
17 Healthcare policy 
Develop strategies to influence/change healthcare policy to 
support the implementation and maintenance of OAMPs 
9.00 5.5 7 
5 
Skills, confidence and training of 
HCP delivering OAMPs 
Develop and assess competency standards (certification) for all 
HCPs delivering OA Management Programs  
9.75 7.63 8 
12 
Reimbursements of out-of-
pocket for OAMP participants 
(public, private, insurance) 
Develop strategies to engage healthcare policy and insurance 
agencies to limit out-of-pocket expenses for OA Management 
Program participants 
10.25 10.0 9 
14 
Provision of accurate 
information for consumers 
Develop and maintain resources that provide accurate, evidence-
based information for people living with OA. 
10.50 2.25 10 
3 
Operational funding for 
programs 
Develop and assess strategies to secure and maintain operational 
funding for OA Management Programs  
11.00 10.25 11 
13 Stakeholder engagement 
Implement and assess strategies that aim to achieve broad OA 
Management Program stakeholder engagement within the greater 
implementation framework 
11.25 8.12 12 
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10 
A core recommended set of 
outcome measures for OAMPs  
Develop a set of minimum core set of outcome measures for 
OAMPs 
12.25 7.37 13 
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Identification of domains, key topics and 
multiple choice questions by the study team
Development and circulation of survey 1 in 
REDCap software (n=115)
Completion of survey 1 by invited participants 
(n=51, 44%)
Analysis of survey 1 results and identification 
of top 20 topics chosen by participants
Synthesis of top 20 topics into 17 action 
statements for the Initiative to undertake 
Circulation of survey 2 to consenting 
participants (n=40)
Completion of survey 2 (ranking of statements) 
via 1000minds (n=26, 65%) 
Analysis of results and identification of the top 
5 priorities for action
Previous priority topics 
discussed by the Initiative
Review of topics and 
consensus by study team
Circulation of final priority 
results to the Initiative 
members for discussion
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operational funding
healthcare systems
stakeholder engagement
reimbursement for participants
healthcare policy
governance
electronic medical record
safe and appropriate
low SE counries
other
environmental features
mode of delivery
 specialised skill sets for OA professionals
accurate information for consumers
Training for OA management personnel
updating with most current knowledge
overarching framework
general skill sets for OA professionals
comorbidities
defining roles for HCP
accessability
socioeconomic considerations
cultural considerations
Competencies for HCP
other
managing therapeutic affects / behaviour change
HP engagement with program
consumer engagement with program
self-management
cost-effectiveness
function
pain
QoL
long term program monitoring
consumer adherance
sharing challenges of implimentation
research collaboration
other
clinical outcomes vs cost
skills, confidence and training for HCP
novel models of OAMP
adherence to international OA guidelines
core outcome measures for OAMP
quality of care
core interventions of OAMP
No. of responses (n)
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1
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